Ginkgo Bioworks Holdings (DNA) Operating Income (2020 - 2025)
Historic Operating Income for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to -$90.0 million.
- Ginkgo Bioworks Holdings' Operating Income fell 6306.25% to -$90.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$348.1 million, marking a year-over-year increase of 4511.28%. This contributed to the annual value of -$559.8 million for FY2024, which is 3524.37% up from last year.
- Per Ginkgo Bioworks Holdings' latest filing, its Operating Income stood at -$90.0 million for Q3 2025, which was down 6306.25% from -$65.5 million recorded in Q2 2025.
- Ginkgo Bioworks Holdings' 5-year Operating Income high stood at -$26.7 million for Q3 2021, and its period low was -$1.7 billion during Q4 2021.
- Over the past 5 years, Ginkgo Bioworks Holdings' median Operating Income value was -$178.1 million (recorded in 2023), while the average stood at -$300.3 million.
- As far as peak fluctuations go, Ginkgo Bioworks Holdings' Operating Income tumbled by 291448.43% in 2021, and later skyrocketed by 8629.67% in 2022.
- Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' Operating Income stood at -$1.7 billion in 2021, then surged by 86.3% to -$230.9 million in 2022, then rose by 22.85% to -$178.1 million in 2023, then skyrocketed by 41.83% to -$103.6 million in 2024, then rose by 13.12% to -$90.0 million in 2025.
- Its Operating Income stands at -$90.0 million for Q3 2025, versus -$65.5 million for Q2 2025 and -$89.0 million for Q1 2025.